- Home
- Companies
- asia middle east
- drug for the treatment
Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Automobile & Ground Transport
- Defense
- Electronics and Computers
- Aerospace & Air Transport
- Waste and Recycling
- Oil, Gas & Refineries
- Monitoring and Testing
- Environmental
- Health and Safety
- Air and Climate
- University / Academia / Research
- Government
- Manufacturing, Other
- Publishing / Media / Marketing
- Food and Beverage
Drug For The Treatment Suppliers In Asia Middle East
8 companies found
based inInnsbruck, AUSTRIA
IONICON is the world's leading manufacturer of ultra-sensitive real-time trace gas analyzers based on the unique Proton Transfer Reaction – Mass Spectrometry (PTR-MS) and proprietary SRI-MS technology. IONICON also produces industrial process ...
based inAnyang City, CHINA
COMCESS has an annual output of 1000,000 cubic meters of ion exchange resin. Mainly produces strong acid, strong base, weak acid, weak base macroporous adsorption resin, etc. Mainly used in industrial water treatment, food, medicine, plant ...
based inTel-Aviv, ISRAEL
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of ...
RHB-204 is a proprietary, fixed-dose oral capsule containing a combination of clarithromycin, rifabutin, and clofazimine, developed for the treatment of pulmonary NTM disease caused by Mycobacterium avium Complex (MAC). ...
based inSeoul, SOUTH KOREA
GI Innovation is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and ...
based inRiga, LATVIA
Longenesis has created an end-to-end environment for biomedical institutions, patient organizations and research partners and sponsors - to communicate directly, enabling both safe data curation and compliant, consent-enabled biomedical data ...
based inMoscow, RUSSIA
NANOLEK is a modern, fast-growing Russian biopharmaceutical company, specializing in the production of import-substituting and innovative drugs. Our high-tech full-cycle production facilities fully comply with GMP and ISO standards. Our portfolio ...
Disease-modifying drug for the treatment of HIV; a second-generation protease inhibitor forming part of standard first-line treatments of ...
based inNoida, INDIA
IMARC offers market research reports and consulting services to clients consisting of, but not limited to, SMEs and Fortune 500 companies. Our team of skilled analysts focuses on understanding the requirements of our clients so as to provide ...
Market/Product assessment reports give our clients a deep insight into the dynamics of the Industry. These studies serve as an analytical as well as a statistical tool to understand the regulations, trends, market structure, sales, supply chain, ...
based inPanchkula, INDIA
We are among the top group in the pharma franchise company in India who holds WHO, GMP and GLP certifications. Our marketing departments, which are run by our highly skilled and experienced specialists, are in charge of delivering high-quality, safe ...